LUSTIG MARC purchased 55.1% of their position (902.93K shares) of BRIACELL THERAPEUTICS CORP. on the open market
Open‑market purchase worth $2.00M — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 5/20/2024ACC: 0001493152-24-020660
+1.81M
Net shares
Net buyer
$2.00M
Total acquired
1
Open market trades
1B · 0S
2
Total transactions
1.81M acquired
Non-Derivative Transactions1
Common Shares
Indirect
Shares
+902.93K
Price / share
$2.21
Trade value
$2M
% of position
55.1%
5/14/2024
1.64M→2.54M
Total
Net shares
+902.93K
Net value
$2M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Shares Indirect | 5/14/2024 | P · Purchase | +902.93K | $2.21 | $2M | 55.1% | 1.64M | 2.54M |
| Total | +902.93K | $2M | ||||||
Derivative Transactions1
Common Stock Warrants
Indirect
Converts to
Common Stock
902.93K shares
Shares
+902.93K
Strike price
2.11
Held after
902.93K
Exercisable
—
5/14/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Common Stock Warrants Indirect | Common Stock902.93K shares | 5/14/2024 | P · Purchase | +902.93K | 2.11 | — | 902.93K |